lipofectamineLTX_and_PLUS_man
发布时间:2021-06-08
发布时间:2021-06-08
Lipofectamine®
LTX & Plus Reagent
*Plus Reagent (Cat. no. 11514-015) available separately.
Pub. Part No. 15338.pps
Pub. No. MAN0001225
Rev. Date 20 July 2012
Description
Lipofectamine® LTX and Plus Reagent are proprietary formulations for
transfecting nucleic acids into a wide range of eukaryotic cells. Nucleic acid-Lipofectamine® LTX complexes can be added directly to
cells in culture medium, in the presence or absence of serum/antibiotic.
It is not necessary to remove complexes or change/add medium after transfection.
Important Guidelines for Transfection
Use Opti-MEM® I Reduced Serum Medium (Cat. no. 31985-062) to
dilute Lipofectamine® LTX Reagent and nucleic acids.
The amount of Lipofectamine® LTX Reagent required for successful transfection varies depending on the cell type and passage number. Start any new transfection by testing the recommended four concentrations of Lipofectamine® LTX Reagent to determine an optimum amount.
For additional information, and protocols on transfecting suspension cells refer to the manual at /transfection
For research use only. Not for human or animal therapeutic or diagnostic use.
下一篇:HS5104 红外遥控编码发射器